| Literature DB >> 31417661 |
Dora Praksch1, Barbara Sandor1, David Kovacs1, Peter Petrovics2, Krisztina Kovacs3, Kalman Toth1, Eszter Szabados2.
Abstract
BACKGROUND: Data in the literature concerning the effects of physical activity on lipid and IGF-1levels are controversial in postmenopausal women. The aim of the present study was to determine the combined effects of a 12 weeks home-based walking program aiming to achieve 10,000 steps daily and a center- based aerobic exercise training on functional capacity, some important cardio-metabolic parameters, IGF-1 level and psychological items among elderly female patients. Sixty female patients (67.4 ± 5 years) with moderate to high cardiovascular risk were randomly assigned either to an exercise training program for 12 weeks or to the control group.Entities:
Keywords: Cardio-metabolic health; Elderly female patients; IGF-1; Physical activity
Year: 2019 PMID: 31417661 PMCID: PMC6688290 DOI: 10.1186/s11556-019-0220-7
Source DB: PubMed Journal: Eur Rev Aging Phys Act ISSN: 1813-7253 Impact factor: 3.878
Characteristics of the study population, n = 60
| population characteristic | training group ( | control group ( | |
|---|---|---|---|
| hypertension | 29 (96%) | 27 (90%) | 0.30 |
| diabetes mellitus | 10 (33%) | 9 (30%) | 0.78 |
| dyslipidemia | 19 (63%) | 15 (50%) | 0.29 |
| chronic kidney disease | 2 (3.3%) | 0 (0%) | 0.15 |
Medication therapy during the 12 week training program, n = 60
| medication | training group ( | control group ( | |
|---|---|---|---|
| statins | 19 (63%) | 15 (50%) | 0.29 |
| antiplatelet drugs | 9 (30%) | 7 (23%) | 0.56 |
| β-blocker | 15 (50%) | 14 (46%) | 0.79 |
| RAAS inhibitor | 20 (66%) | 14 (46%) | 0.12 |
| calcium channel blocker | 8 (26%) | 9 (30%) | 0.77 |
| antidiabetic drugs | 10 (33%) | 9 (30%) | 0.78 |
| diuretics | 12 (40%) | 8 (26%) | 0.27 |
RAAS renin–angiotensin–aldosterone system
Fig. 1Significant changes in metabolic equivalent (MET) within and between the groups. Values are shown baseline and 12 weeks (mean ± SD). Levels of significance p < 0.005. *: p = 0.002 regarding baseline to 12 weeks in the training group; #: p < 0.01 regarding the training group compare to the control group after 12 weeks
Changes in metabolic laboratory parameters and IGF-1 level after 12 weeks physical activity in the training group. N = 30; values are baseline and 12 weeks means±SD. Levels of significance: p < 0.05
| measured parameters | baseline | 12 week | |
|---|---|---|---|
| HgbA1C (mmol/l) | 6.24 ± 0.67 | 6.06 ± 0.58 | 0.007 |
| total cholesterol (mmol/l) | 5.17 ± 1.13 | 4.77 ± 1.12 | 0.042 |
| LDL-cholesterol (mmol/l) | 3.37 ± 1.05 | 2.81 ± 0.98 | 0.003 |
| HDL-cholesterol (mmol/l) | 1.46 ± 0.39 | 1.51 ± 0.46 | ns |
| triglycerides (mmol/l) | 1.68 ± 0.71 | 1.28 ± 0.71 | 0.002 |
| IGF-1 (ng/ml) | 59.68 ± 27.37 | 66.79 ± 22.74 | 0.006 |
Fig. 2Box plots of cardio-metabolic parameters and IGF-1 level at baseline and after 12 weeks between the training-, and the control group. n = 60. Levels of significance: p < 0.05. a Significant difference in MET between the groups. p = 0.003. b Significant difference in LDL-cholesterol level between the groups. p = 0.046. c Significant difference in triglyceride level between the groups. p = 0.001. d Significant difference in IGF-1 level between the groups. p < 0.001